×

Concurrent Use of Sorafenib and Stereotactic Body Radiotherapy for Advanced Liver Cancer Patients is Not Recommended Outside of Clinical Trials

CONTACT: Michelle Kirkwood, 703-286-1600, michellek@astro.org

American Society for Radiation Oncology